INTRODUCTION
Inflammatory Bowel Disease C D U C affects an estimated 1.5million people in North America, 2.2 million people in Europe and several hundred thousand more worldwide with a globally rising incidence in children and young people (1 3) . Around 20-30% of inflammatory bowel disease presents in childhood (4) with a peak onset in adolescence (1) and with a younger age at presentation being a risk factor for poor disease prognosis (5) . Young people living with inflammatory bowel disease face a range of issues and challenges that can represent a major psychosocial burden leading to a loss of self-esteem and self-confidence, poorer quality of life, and heightened levels of psychological distress (6) . Adolescents with inflammatory bowel disease have been estimated to be at 4.6 fold increased risk of clinically significant symptoms of anxiety or depression than healthy peers (7).
Inflammatory bowel disease has also been demonstrated to have a detrimental impact nships (8,9). Cognitive behavioural therapy has been demonstrated to improve mood and quality of life in adolescents with IBD and subsyndromal depression (10). European guidelines recommend that patients with inflammatory bowel disease are screened for anxiety, depression and if indicated refer for psychotherapeutic interventions (11, 12) . A recent worldwide survey of health care professionals caring for inflammatory bowel disease patients perceive that mental health assessment should be standard IBD care (13).
However, a defined pathway for referral is available in only 12% of UK adult inflammatory bowel disease centres, to which young people transition from the age of 16, compared to two-thirds in paediatric care (14), and as a result psychological morbidity is frequently untreated in inflammatory bowel disease (15).
Two reviews have examined aspects of psychological functioning and adjustment in young people with inflammatory bowel disease. Greenley et al. (16) examined psychosocial adjustment of young people (<18 years) with inflammatory bowel disease.
The review, which included only studies with a comparison group or those where published normative data was available, found that subjects with inflammatory bowel disease had higher rates of depressive disorders and internalising conditions compared to other chronic conditions such as cystic fibrosis, diabetes and malignancy. Ross et al. (17) found an increased incidence of psychiatric disorders (anxiety and depression) using standard diagnostic interviews in young people (<18 years) with IBD. However, identifying psychological morbidity in young people with inflammatory bowel disease is difficult due to the overlapping nature of symptoms which may be related to organic disease, adverse effects of medications or due to psychological morbidity (18) .
Furthermore, difficulties arise because studies and reviews classify young people according to differing age groups, with studies examining paediatric populations (<16 years), youth (<18 years) or adults (>18 years). The World Health Organisation defines adolescence as the developmental stage between 10-19 years, and youth as 15-24years. In addition, classification, prevalence and incidence of psychological distress are difficult to define (16, 19) due to lack of consistent use of diagnostic criteria of DSM-IV (20) in research settings. In line with World Health Organisation recommendations, this review treats two age groups (adolescence and youth) as a single group aged 10-24years, referred to as young people throughout. This age group is a critical time for young people, service provision through to adult care, and from parent-led care to self-management whilst at a life stage characterised by change, exploration, risk-taking and identity development.
Health care professionals managing young people with IBD need to be aware of the possible consequences of psychological morbidity and be adept at identifying those at risk of psychological morbidity. This systematic review therefore aims to synthesize the available evidence regarding the impact of psychological morbidity in young people with inflammatory bowel disease and associated risk factors and to make recommendations regarding future research and service development in this area.
REVIEW CRITERIA AND METHODOLOGY
This systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
Data Sources and Search Strategy
A systematic literature search was undertaken using four relevant databases, Medline be extricated from the presented data (b) they were case studies or not empirical 8 studies (e.g. narrative reports, reviews), and (c) they were only published in abstract.
Additional studies of interest were identified by hand searches of bibliographies and cited references and by consultation with clinical experts in the field.
Data extraction and Quality Assessment
30 studies were included for review ( Figure 1 ; (21)). Of these, 24 were conducted in North America and 6 in Europe. The median number of participants in the studies was 79 (range 20-2144), mean age 14.7 years (range 8-18years) with an inflammatory bowel disease type of 83% C ; 16% ulcerative colitis and 1% inflammatory bowel disease unclassified. A formal assessment of study quality was conducted using the GRADE system (22) with 15 (50%) being graded as low and 15 as very low in quality.
28/30 studies reviewed were cohort, cross sectional designs investigating psychological morbidity, psychosocial burden and factors associated with these and related outcomes (see Tables 1, 2 Gender. Four studies have examined whether there is a relationship between gender and psychological morbidity in young people with inflammatory bowel disease, with three studies suggesting no association (25, 26, 33 Of the studies reporting no relationship with disease severity and psychological morbidity one of these report that patients with mild inflammatory bowel disease diagnosed for > 1 year have psychosocial functioning similar to that of controls, and disease severity did not differ in those with or without depressive symptoms (40) .
RESULTS

RISK FACTORS FOR PSYCHOLOGICAL MORBIDITY
However, this study had a small sample size, a C predominant cohort and 93.6% of patients with mild or inactive disease). In a second small study examining predictors of depression in new onset inflammatory bowel disease (<3months) Burke et al. (37) found that the depressed group had significantly less severe disease than the non-depressed group (P=0.006). Finally, Herzog and colleagues examined C Depression Inventory scores and found no relationship with inflammatory markers (Creactive protein) or disease scores (33 Immunosuppressive Drugs. performed a large population study based on medical claims, prescription drug claims, and enrolment data in which they compared the risks of developing psychological morbidity (anxiety and depression) with the incidences of psychotropic medication.
After controlling for patient characteristics including comorbidity profiles, health plan types and geographical variation, young people with C were 2-times more likely to receive psychotropic drugs than C -free age, sex and health plan enrolment matched controls. The likelihood of receiving a tricyclic antidepressant in the C group was 4 times greater than controls (HR=4.16, 95% CI=2.76-6.27) (34). This increase in tricyclic antidepressant use may in part be explained by functional bowel symptoms following CD diagnosis, but this was not assessed by the investigators.
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Of note patients with any mental health disorders or psychotropic medication use before the index date were excluded.
Sleep.
The relationship between sleep and psychological morbidity in depressed young people with C has been examined in two recent cross-sectional studies (56, 57) . Benhayon and colleagues (56) Illness Perception. Subjective illness perception and its relationship with psychological morbidity has been investigated in two studies (28, 35) . In the first study (35) , depressive symptoms were measured through negative affectivity and were compared to subjective illness severity (pain, behaviour, fatigue). Negative affectivity correlated significantly with subjective symptoms, and it was estimated that 34% of variance in subjective illness severity was accounted for by negative affectivity, whilst being 14.
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